Delivery Order SPE2DB24D2215-SPE2DB25FGTEC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $31,584.28 to AmerisourceBergen Drug Corp for the supply of Keppra (levetiracetam) 1,000 mg tablets in quantities of 60 units. This competitively awarded, firm fixed-price delivery order was issued on July 23, 2025, with an ultimate completion date of July 24, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $21,613.75 to AmerisourceBergen Drug Corp for the supply of Keppra 500 mg tablets (120-count units) under a firm fixed price contract. The award was made on July 28, 2025, with an ultimate completion date of July 29, 2025, and does not utilize a set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this contract. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Keppra XR 750 mg tablets (60-count packages) valued at $1,026.97. This firm fixed-price, non-set-aside contract was awarded on July 22, 2025, with an ultimate completion date of July 23, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting federal medical supply...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Keppra 1,000 mg tablets. The contract has a ceiling value of $7,792.24 and an ultimate completion date of November 28, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for AmerisourceBergen...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $3,409.35 firm fixed-price delivery order is for the supply of KEPPRA 500 MG TABLET 120S, a medication, to support military healthcare programs. The contract has an ultimate completion date of March 25, 2025 and was awarded on March 24, 2025. It is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite...
- This is a $4,504.98 firm-fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of KEPPRA 500 MG TABLET 120S, a neurological medication, with a period of performance through June 17, 2025. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX,...
- This is a $13,617.27 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The award is for the supply of KEPPRA 100 MG/ML ORAL SOLN 473ML, a prescription medication. The contract has an ultimate completion date of August 13, 2024 and is not set aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December...
- This federal contract award is for pharmaceutical products and medical supplies, specifically Keppra 500 MG tablets, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $7,478.10 and was awarded on October 18, 2023, with an ultimate completion date of October 19, 2023. The contract is a Delivery Order under a Firm Fixed Price (FFP) structure, with no set-aside designation. AmerisourceBergen Drug Corp...
- This federal contract award is for the delivery of Keppra 1,000 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a delivery order valued at $1,468.38, has an ultimate completion date of April 29, 2024. It is a firm fixed-price contract, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,691.77, is for the delivery of KEPPRA 500 MG TABLET 120S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of December 31, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant...
- SPE2DB24D2215Indefinite Delivery Contract
- SPE2DB24D2215-SPE2DB25FGTECDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,469.62 to AmerisourceBergen Drug Corp for the supply of Keppra 1,000 mg tablets in quantities of 60 units. This competitively awarded, firm fixed-price contract carries an ultimate completion date of August 4, 2025, with performance to be fulfilled at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-set-aside procurement, indicating open competition among qualified pharmaceutical distributors. This delivery order derives from AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply medications, vaccines, medical devices, and specialty pharmaceuticals to support military healthcare programs worldwide. AmerisourceBergen's extensive federal contract portfolio demonstrates its established capability as a major pharmaceutical distributor for Department of Defense medical supply chain requirements, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 8/1/25 |